IL90781A0 - 5-oxygenated hmg-coa reductase inhibitors and pharmaceutical compositions containing them - Google Patents

5-oxygenated hmg-coa reductase inhibitors and pharmaceutical compositions containing them

Info

Publication number
IL90781A0
IL90781A0 IL90781A IL9078189A IL90781A0 IL 90781 A0 IL90781 A0 IL 90781A0 IL 90781 A IL90781 A IL 90781A IL 9078189 A IL9078189 A IL 9078189A IL 90781 A0 IL90781 A0 IL 90781A0
Authority
IL
Israel
Prior art keywords
hmg
coa reductase
reductase inhibitors
oxygenated
pharmaceutical compositions
Prior art date
Application number
IL90781A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/250,646 external-priority patent/US4921974A/en
Priority claimed from US07/322,398 external-priority patent/US4963538A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL90781A0 publication Critical patent/IL90781A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL90781A 1988-06-29 1989-06-29 5-oxygenated hmg-coa reductase inhibitors and pharmaceutical compositions containing them IL90781A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21301088A 1988-06-29 1988-06-29
US07/250,646 US4921974A (en) 1988-09-29 1988-09-29 Intermediates and processes in the preparation of 5-oxygenated HMG-COA reductase inhibitors
US07/322,398 US4963538A (en) 1988-06-29 1989-03-13 5-oxygenated HMG-CoA reductase inhibitors

Publications (1)

Publication Number Publication Date
IL90781A0 true IL90781A0 (en) 1990-01-18

Family

ID=27395805

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90781A IL90781A0 (en) 1988-06-29 1989-06-29 5-oxygenated hmg-coa reductase inhibitors and pharmaceutical compositions containing them

Country Status (14)

Country Link
EP (1) EP0349063B1 (de)
JP (1) JPH0253752A (de)
KR (1) KR910000694A (de)
AT (1) ATE127798T1 (de)
AU (1) AU619563B2 (de)
CA (1) CA1328876C (de)
DE (1) DE68924205T2 (de)
DK (1) DK319989A (de)
FI (1) FI893004L (de)
HU (1) HUT50803A (de)
IL (1) IL90781A0 (de)
NO (1) NO892677L (de)
NZ (1) NZ229671A (de)
PT (1) PT90958B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT88364A (pt) * 1987-09-02 1989-07-31 Merck & Co Inc Process for preparing novel hmg-coa reductase inhibitors
US5200549A (en) * 1988-11-14 1993-04-06 Hoffman-La Roche Inc. Antipsoriatic agents
US5073568A (en) * 1988-11-14 1991-12-17 Hoffmann-La Roche Inc. Antipsoriatic agents
CA2036962C (en) * 1990-02-26 1998-09-15 Ann E. Decamp Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one
US5059696A (en) * 1990-03-15 1991-10-22 Merck & Co., Inc. Processes and intermediates for the preparation of 5-oxygenated hmg-coa reductase inhibitors
MY106564A (en) * 1990-07-06 1995-06-30 Squibb & Sons Inc Sulfur-substituted mevinic acid derivatives.
US5286746A (en) * 1991-12-20 1994-02-15 E. R. Squibb & Sons, Inc. Sulfur-substituted mevinic acid derivatives
US5369123A (en) * 1992-10-09 1994-11-29 E. R. Squibb & Sons, Inc. Nitrogen-substituted mevinic acid derivatives useful as HMG-CoA reductase inhibitors
SI20159A (sl) * 1999-02-04 2000-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nov postopek za odstranitev sililoksi zaščitne skupine iz 4-sililoksi tetrahidro-piran-2-on-ov
SI21187A (sl) * 2002-03-26 2003-10-31 Krka, Tovarna Zdravil D.D., Novo Mesto Postopek za pripravo 4-oksitetrahidropiran-2-onov
KR20200066690A (ko) 2017-10-16 2020-06-10 칭화대학교 메발로네이트 경로 억제제 및 이의 약제학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56150037A (en) * 1980-04-22 1981-11-20 Sankyo Co Ltd Hydronaphthalene compound
JPS58188872A (ja) * 1982-04-26 1983-11-04 Suntory Ltd オクタヒドロナフタレン誘導体及びその製造法
JPS59186972A (ja) * 1983-03-09 1984-10-23 Suntory Ltd オクタヒドロナフタレン誘導体並びにその製造法
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors
PT88364A (pt) * 1987-09-02 1989-07-31 Merck & Co Inc Process for preparing novel hmg-coa reductase inhibitors

Also Published As

Publication number Publication date
DK319989A (da) 1990-01-02
FI893004A0 (fi) 1989-06-19
FI893004A7 (fi) 1989-12-30
KR910000694A (ko) 1991-01-30
DE68924205T2 (de) 1996-03-28
PT90958A (pt) 1989-12-29
JPH0253752A (ja) 1990-02-22
FI893004L (fi) 1989-12-30
DK319989D0 (da) 1989-06-28
NO892677L (no) 1990-01-02
AU3711689A (en) 1990-01-04
EP0349063B1 (de) 1995-09-13
HUT50803A (en) 1990-03-28
EP0349063A3 (en) 1990-05-09
AU619563B2 (en) 1992-01-30
ATE127798T1 (de) 1995-09-15
CA1328876C (en) 1994-04-26
PT90958B (pt) 1994-11-30
NO892677D0 (no) 1989-06-27
DE68924205D1 (de) 1995-10-19
NZ229671A (en) 1991-11-26
EP0349063A2 (de) 1990-01-03

Similar Documents

Publication Publication Date Title
AU5027393A (en) Benzo-fused lactams
NO901392D0 (no) Immunomodulerende azaspiraner.
LV11033A (lv) Mevinskabju un to analogu laktonizacijas panemiens
AU3980793A (en) Pharmaceutical compounds
DK51087D0 (da) Antihypercholesterolaemiske forbindelser
IL90781A0 (en) 5-oxygenated hmg-coa reductase inhibitors and pharmaceutical compositions containing them
GR3025151T3 (en) Derivatized alkanolamines as cardiovascular agents
IL123063A (en) Sidechain-bearing taxanes
AU2623192A (en) Antifungal agent
RU94046387A (ru) Производные пиримидина, способ их получения, фармацевтическая композиция, ее применение и промежуточные продукты
AU4136189A (en) Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles
HUT65082A (en) 2-aryl-pyrimidine derivatives and herbicid compositions containing them
EP0245003A3 (de) Antihypercholesterolemische Verbindungen
YU127289A (sh) INHIBITORI 5-OKSIGENISANE HMG-CoA REDUKTAZE
AU652394B2 (en) Novel antitumoral and antiviral compound
EP0521571A3 (en) Procedure for the preparation of bicyclo (3.2.0) hept-2-en-7-ones
ATE135352T1 (de) 3-keto-hmg-coa reduktase-inhibitoren
EP0210607A3 (en) (meth)acrylic esters and their use